A 5-year follow-up on antibody response after diphtheria and tetanus vaccination in hemodialysis patients.
@article{Krger2001A5F,
title={A 5-year follow-up on antibody response after diphtheria and tetanus vaccination in hemodialysis patients.},
author={S. Kr{\"u}ger and Michael Müller-Steinhardt and Holger Kirchner and Burkhard Kreft},
journal={American journal of kidney diseases : the official journal of the National Kidney Foundation},
year={2001},
volume={38 6},
pages={
1264-70
}
}Chronic renal failure is associated with a T-cell-dependent immune defect. In the past, various studies have focused on the insufficient immune response to vaccination of hemodialysis patients. An impaired vaccination response rate has been reported for vaccines against hepatitis B, influenza, tetanus, diphtheria, and others. However, no data exist on the long-term success of vaccination against tetanus and diphtheria in these patients. The aim of the present study is to investigate…
60 Citations
Protective Status of End-Stage Renal Disease Children Against Tetanus and Diphtheria Vaccination
- Medicine, BiologyInternational journal of preventive medicine
- 2013
Evaluating the protective status of vaccination against diphtheria and tetanus in ESRD children after completing routine vaccination revealed that in 91% of hemodialysis patients and 83% of peritoneal dialysis children booster doses of tetanus were recommended.
Evaluation of Anti-Tetanus Immunity in Haemodialysis Patients
- Medicine, Biology
- 2009
Hemodialysis duration has significant effect on antitetanus immunity level, and of the evaluating factors just hemodialysisduration found to affect on tetanus immunity.
Tetanus antitoxin levels and cutaneous anergy in hemodialysis patients in two university hospitals in Iran
- Medicine, Biology
- 2006
The results indicate that immunization history was not consistent with protective antibody level, so monitoring immunization status and administering the tetanus vaccine in hemodialysis patients are required.
A Study on the Protection of Hemodialysis Patients Against Diphtheria and Tetanus
- Medicine, BiologyRenal failure
- 2009
It is concluded that in this study, the level of the antitetanus IgG antibody (unlike the antidiphtheria IgG antibodies level) is significantly different among the hemodialysis patients, the chronic hemodialsis patients, and the control group.
Seroprevalence of Antibodies against Diphtheria, Tetanus and Pertussis in Adult At-Risk Patients
- Medicine, BiologyVaccines
- 2021
It is concluded that except for tetanus, the vast majority of at-risk patients remains susceptible to vaccine-preventable diseases such as diphtheria and pertussis.
Immunogenicity of a standard trivalent influenza vaccine in patients on long-term hemodialysis: an open-label trial.
- Medicine, BiologyAmerican journal of kidney diseases : the official journal of the National Kidney Foundation
- 2009
Influenza vaccination is as efficacious in HD patients as in healthy volunteers and none of the investigated parameters of nutrition, inflammation, and dialysis adequacy had a significant impact on the immune response.
Lack of serologic immunity against vaccine‐preventable diseases in children after thoracic transplantation
- Medicine, BiologyTransplant international : official journal of the European Society for Organ Transplantation
- 2010
The study shows that closer adherence to pretransplantation vaccination schedules and also post‐transplantation monitoring of antibody levels are required in transplant patients.
Effect of levamisole supplementation on tetanus vaccination response rates in haemodialysis patients: A randomized double‐blind placebo‐controlled trial
- Medicine, BiologyNephrology
- 2014
Levamisole as an immunomodulator drug has been demonstrated to improve the immune response to hepatitis B virus vaccination in haemodialysis patients. The aim of this randomized double‐blind…
Erythropoietin Use and Immunogenicity of Hepatitis B Virus Vaccine in Chronic Kidney Disease Patients: A Meta-Analysis
- Medicine, BiologyKidney and Blood Pressure Research
- 2012
A systematic review of the literature with a meta-analysis of clinical studies showed no link between immunological response to HBV vaccine and therapy with human recombinant erythropoietin among individuals on long-term dialysis.
Stage of chronic kidney disease predicts seroconversion after hepatitis B immunization: earlier is better.
- MedicineAmerican journal of kidney diseases : the official journal of the National Kidney Foundation
- 2003
This is the largest study to show in a well-characterized cohort that patients with higher GFR levels are more likely to respond to hepatitis B vaccination programs with seroconversion, independent of other factors.
References
SHOWING 1-10 OF 25 REFERENCES
Defective immune response to tetanus toxoid in hemodialysis patients and its association with diphtheria vaccination.
- Medicine, BiologyVaccine
- 1999
Low efficiency of active immunization against diphtheria in chronic hemodialysis patients.
- Medicine, BiologyKidney international
- 1997
It is suggested to monitor antibodies against diphtheria toxoid in vaccinated hemodialysis patients at risk for diphTheria since protective titers are often not attained by the standard vaccination protocol.
Prospective analysis of the factors influencing the antibody response to hepatitis B vaccine in hemodialysis patients.
- Medicine, BiologyAmerican journal of kidney diseases : the official journal of the National Kidney Foundation
- 1997
Pneumococcal vaccine in children and young adults with chronic renal disease.
- Medicine, BiologyNephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association
- 1996
The currently available pneumococcal vaccine is without major side-effects and effective in producing a significant immune response and antibody levels should be monitored in vaccinated patients with chronic renal diseases considering the rapid decline as early as 6 months after vaccination.
Active hepatitis B vaccination of dialysis patients and medical staff.
- Medicine, BiologyKidney international
- 1984
In dialysis patients who fail to develop anti-HBs after three doses of vaccine, a fourth vaccination is recommended after 12 months and a fifth vaccination only led to seroconversion, when brief or borderline anti- HBs could already be demonstrated previously.
[Sex and age-dependent gaps in tetanus immunization].
- Medicine, BiologyDeutsche medizinische Wochenschrift
- 1994
In the whole group the titre level decreased with age, while the proportion of unprotected persons increased, and attention should also be paid to the lack of protective antibodies in newborns and the marked gaps of immunity among children.
A Population-Based Serologic Survey of Immunity to Tetanus in the United States
- Medicine
- 1995
Background Vaccination rates are frequently considered a surrogate measure of protection. To provide more accurate estimates, serum levels of antibody against tetanus were measured as part of the…
The serological assessment of a tetanus toxoid field trial.
- MedicineBulletin of the World Health Organization
- 1971
It is suggested that the level of protection may be lower than is at present accepted and one injection of specially prepared toxoid with a high immunizing potency might give significant protection.




